tranexamic acid has been researched along with Hemorrhagic Disorders in 20 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Hemorrhagic Disorders: Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0." | 7.73 | Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005) |
| "Tranexamic acid was administered for menorrhagia and resumed later for labor and continued into the postpartum period since antifibrinolytics have been the mainstay in the management of PAI-1 deficiency." | 5.56 | The utility of thromboelastography and tranexamic acid in plasminogen activator inhibitor deficiency during pregnancy: a rare case report. ( Hammer, RD; Laziuk, K; Prabhakaran, N, 2020) |
| " Systematic review and meta-analysis to determine the bleeding rates associated with tranexamic acid, desmopressin, platelet transfusion, plasma transfusion and recombinant activated factor VII, for patients with unclassified bleeding disorders undergoing surgery, childbirth or with menorrhagia." | 5.12 | Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies. ( Desborough, MJR; Doree, C; Lowe, GC; Obaji, S; Thomas, W, 2021) |
| " To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0." | 3.73 | Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005) |
| "Tranexamic acid has been advocated for patients with severe bleeding tendency due to thrombocytopenia not responding to platelet transfusions." | 3.69 | Microscopic haematuria as a relative contraindication for tranexamic acid. ( Schultz, M; van der Lelie, H, 1995) |
| "The morbidity and mortality of postpartum hemorrhage (PPH) in women with an underlying bleeding disorder requires vigilance by the hematologist." | 2.52 | An update on the management of bleeding disorders during pregnancy. ( Kouides, PA, 2015) |
| "Tranexamic acid was administered for menorrhagia and resumed later for labor and continued into the postpartum period since antifibrinolytics have been the mainstay in the management of PAI-1 deficiency." | 1.56 | The utility of thromboelastography and tranexamic acid in plasminogen activator inhibitor deficiency during pregnancy: a rare case report. ( Hammer, RD; Laziuk, K; Prabhakaran, N, 2020) |
| "Medroxyprogesterone acetate treatment for her dysfunctional uterine bleeding was unsuccessful." | 1.32 | Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review. ( Osswald, M; Repine, T, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, S | 1 |
| Acharya, SS | 1 |
| Prabhakaran, N | 1 |
| Laziuk, K | 1 |
| Hammer, RD | 1 |
| MacDonald, S | 1 |
| Wright, A | 1 |
| Beuche, F | 1 |
| Downes, K | 1 |
| Besser, M | 1 |
| Symington, E | 1 |
| Kelly, A | 1 |
| Thomas, W | 2 |
| Desborough, MJR | 1 |
| Obaji, S | 1 |
| Lowe, GC | 1 |
| Doree, C | 1 |
| Charpentier, V | 1 |
| Ives, ST | 1 |
| Nogami, K | 1 |
| Matsumoto, T | 1 |
| Sasai, K | 1 |
| Ogiwara, K | 1 |
| Arai, N | 1 |
| Shima, M | 1 |
| Davis, A | 1 |
| Walsh, M | 1 |
| McCarthy, P | 1 |
| Brown, G | 1 |
| Roberts, S | 1 |
| Tran, H | 1 |
| Street, A | 1 |
| Fong, CY | 1 |
| Kemp, W | 1 |
| Faraoni, D | 1 |
| Rozen, L | 1 |
| Willems, A | 1 |
| Torres, CS | 1 |
| Pereira, LM | 1 |
| Demulder, A | 1 |
| Van der Linden, P | 1 |
| Kouides, PA | 1 |
| Repine, T | 1 |
| Osswald, M | 1 |
| Ontachi, Y | 1 |
| Asakura, H | 1 |
| Omote, M | 1 |
| Yoshida, T | 1 |
| Matsui, O | 1 |
| Nakao, S | 1 |
| Yoshioka, A | 1 |
| Kamitsuji, H | 1 |
| Takase, T | 1 |
| Iida, Y | 1 |
| Tsukada, S | 1 |
| Mikami, S | 1 |
| Fukui, H | 1 |
| Schultz, M | 1 |
| van der Lelie, H | 1 |
| Meijer, K | 1 |
| Smid, WM | 1 |
| Geerards, S | 1 |
| van der Meer, J | 1 |
| Levi, M | 1 |
| Peters, M | 1 |
| Briët, E | 2 |
| Favier, R | 1 |
| Aoki, N | 1 |
| de Moerloose, P | 1 |
| Edlund, M | 1 |
| Blombäck, M | 1 |
| Fried, G | 1 |
| Stavem, P | 1 |
| Hjort, PF | 1 |
| Eikenboom, JC | 1 |
| van der Meer, FJ | 1 |
| Leebeek, FW | 1 |
| Knot, EA | 1 |
| Kluft, C | 1 |
6 reviews available for tranexamic acid and Hemorrhagic Disorders
| Article | Year |
|---|---|
Inherited disorders of the fibrinolytic pathway.
Topics: alpha-2-Antiplasmin; Antifibrinolytic Agents; Blood Platelets; Factor V Deficiency; Fibrinolysis; He | 2019 |
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.
Topics: Antifibrinolytic Agents; Blood Component Transfusion; Deamino Arginine Vasopressin; Disease Manageme | 2021 |
An update on the management of bleeding disorders during pregnancy.
Topics: Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Coagulation Factors; Female; Hemorrhagic | 2015 |
[Blind spots of the diagnostic hemostasis screen].
Topics: Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Blood Coagulation Tests; Child; Diagnosis, Diff | 2000 |
Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
Topics: alpha-2-Antiplasmin; Aminocaproates; Antifibrinolytic Agents; Fibrinolysis; Hemorrhagic Disorders; H | 2001 |
[Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis].
Topics: Adult; alpha-2-Antiplasmin; Hemorrhagic Disorders; Humans; Male; Tranexamic Acid | 1988 |
3 trials available for tranexamic acid and Hemorrhagic Disorders
| Article | Year |
|---|---|
Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment.
Topics: Adult; Aged; Deamino Arginine Vasopressin; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; | 2020 |
Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.
Topics: Adult; Aged; Biopsy; Blood Coagulation Factors; Blood Loss, Surgical; Demography; Endoscopy; Female; | 2013 |
Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time.
Topics: Adult; Bleeding Time; Cross-Over Studies; Deamino Arginine Vasopressin; Double-Blind Method; Female; | 2002 |
11 other studies available for tranexamic acid and Hemorrhagic Disorders
| Article | Year |
|---|---|
The utility of thromboelastography and tranexamic acid in plasminogen activator inhibitor deficiency during pregnancy: a rare case report.
Topics: Adult; Female; Hemorrhagic Disorders; Humans; Plasminogen Activator Inhibitor 1; Pregnancy; Thrombel | 2020 |
Hyperfibrinolysis: An Uncommon Cause of Bleeding in Cirrhosis.
Topics: Antifibrinolytic Agents; Hemorrhagic Disorders; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Age | 2022 |
A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
Topics: Arginine; Fibrin; Fibrin Clot Lysis Time; Fibrinolysis; Hemorrhagic Disorders; Humans; Kinetics; Pip | 2019 |
Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
Topics: Antifibrinolytic Agents; Child; Child, Preschool; Fibrinolysis; Heart Defects, Congenital; Hemorrhag | 2015 |
Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review.
Topics: Adult; Anemia, Iron-Deficiency; Antifibrinolytic Agents; Blood Coagulation Tests; Female; Hemorrhagi | 2004 |
Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid.
Topics: Adult; Antifibrinolytic Agents; Blood Proteins; Chondroitin Sulfates; Dermatan Sulfate; Disseminated | 2005 |
Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
Topics: alpha-2-Antiplasmin; Blood Coagulation Tests; Blood Transfusion; Child, Preschool; Female; Fibrinoly | 1982 |
Microscopic haematuria as a relative contraindication for tranexamic acid.
Topics: Adult; Contraindications; Female; Hematuria; Hemorrhagic Disorders; Humans; Male; Middle Aged; Throm | 1995 |
Hyperfibrinogenolysis in disseminated adenocarcinoma.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brain Ischemia | 1998 |
[Treatment of hemorrhagic diathesis].
Topics: Blood Transfusion; Hemorrhagic Disorders; Humans; Norepinephrine; Plasma; Prednisone; Splenectomy; T | 1975 |
Acquired von Willebrand's disease due to excessive fibrinolysis.
Topics: Blood Coagulation Disorders; Fibrinolysis; Hemorrhagic Disorders; Humans; Male; Middle Aged; Tranexa | 1992 |